Compugen (CGEN) director discloses initial shares, RSUs and option grants
Rhea-AI Filing Summary
Compugen Ltd director Livnat Savitzky Kinneret filed an initial ownership report showing direct holdings of ordinary shares, restricted stock units (RSUs), and stock options. She holds 13,350 ordinary shares, including 9,216 RSUs. Of these RSUs, 1,716 vest in 11 equal quarterly installments commencing on April 1, 2026, and 7,500 vest 25% on October 1, 2026 with the remainder in 12 equal quarterly installments thereafter, all subject to continued service.
The filing also lists several option awards over ordinary shares with exercise prices ranging from $1.15 to $14.40 per share and expiration dates from August 6, 2028 through August 5, 2035. These options have various vesting schedules, including grants that are fully vested and others that vested or vest 25% on specific dates such as April 1, 2023, October 1, 2024, October 1, 2025, and October 1, 2026, with remaining portions in 12 equal quarterly installments, conditioned on her continued service to Compugen.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Footnotes (1)
- Includes 9,216 restricted stock units ("RSUs"). 1,716 RSUs vest in 11 equal quarterly installments commencing on April 1, 2026; and 7,500 RSUs vest 25% on October 1, 2026 and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. Fully vested. This option vested 25% on April 1, 2023 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. This option vested 25% on October 1, 2024 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. This option vested 25% on October 1, 2025 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. This option vests 25% on October 1, 2026 and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.
